SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Krebs Biochemicals to raise funds up to Rs 25 crore

31 Jul 2018 Evaluate

Krebs Biochemicals & Industries has received an approval for raising of funds by way of offer and issue of Equity Shares to the members of the company on rights basis (Rights Issue) at such price and rights entitlement ratio as may be decided by the Board/committee of the Board, for an amount aggregating up to Rs 25 crore. The Board of Directors of the company in its meeting on July 30, 2018, approved the same.

Krebs Biochemicals & Industries is an India-based company. The Company operates in the pharma segment.


Krebs Biochem.&Inds Share Price

60.90 -0.12 (-0.20%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×